02157 樂普生物
公司資料 - 財務狀況表
樂普生物科技股份有限公司 股票編號: 02157
LEPU BIOPHARMA CO., LTD. 集團網址: http://www.lepubiopharma.com
非流動資產
2026/06 - 中期
人民幣(¥)
與去年末期
比較
2025/12
人民幣(¥)
2024/12
人民幣(¥)
2023/12
人民幣(¥)
2022/12
人民幣(¥)
投資物業0--0000
物業、廠房、設備及其他899,851,000-2.942%927,130,000930,106,000948,189,000916,409,000
租賃土地89,962,000-10.294%100,285,000120,932,000139,056,000122,662,000
無形資產584,447,00016.640%501,070,000435,250,000434,221,000450,813,000
聯營公司及共同控制公司權益699,0004.484%669,000114,073,000126,685,000122,392,000
其他非流動資產428,301,0000.014%428,239,00034,816,00059,009,000104,095,000
2,003,260,0002.343%1,957,393,0001,635,177,0001,707,160,0001,716,371,000
存貨74,054,00042.887%51,827,00022,787,00029,412,00024,061,000
 
流動資產
現金及銀行結存684,568,000-19.749%853,030,000401,286,000426,015,000669,397,000
其他流動資產403,781,00070.060%237,434,000221,435,000221,719,000119,343,000
持作出售資產0--0000
1,162,403,0001.761%1,142,291,000645,508,000677,146,000812,801,000
 
流動負債
其他流動負債1,017,642,000-12.428%1,162,059,0001,043,513,000899,561,000843,786,000
持作出售資產相關負債0--0000
1,017,642,000-12.428%1,162,059,0001,043,513,000899,561,000843,786,000
流動資產淨值144,761,000--(19,768,000)(398,005,000)(222,415,000)(30,985,000)
資產總額減流動負債2,148,021,00010.858%1,937,625,0001,237,172,0001,484,745,0001,685,386,000
 
非流動負債
760,864,00032.365%574,821,000555,369,000596,045,000784,624,000
 
資本及儲備
   股本1,804,440,0000.000%1,804,440,0001,710,615,0001,659,445,0001,659,445,000
   儲備(391,238,000)-6.433%(418,136,000)(1,007,790,000)(762,540,000)(758,683,000)
   其他0--0000
股東資金1,413,202,0001.940%1,386,304,000702,825,000896,905,000900,762,000
非控股權益(26,045,000)10.830%(23,500,000)(21,022,000)(8,205,000)0
其他0--0000
1,387,157,0001.787%1,362,804,000681,803,000888,700,000900,762,000
 
承擔及或然負債
承擔----439,484,000457,368,000457,124,000482,651,000
或然負債----0000
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.